These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 15820320)

  • 1. Genetic susceptibility to tardive dyskinesia in chronic schizophrenia subjects: III. Lack of association of CYP3A4 and CYP2D6 gene polymorphisms.
    Tiwari AK; Deshpande SN; Rao AR; Bhatia T; Lerer B; Nimgaonkar VL; Thelma BK
    Schizophr Res; 2005 Jun; 75(1):21-6. PubMed ID: 15820320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic polymorphisms for drug metabolism (CYP2D6) and tardive dyskinesia in schizophrenia.
    Kapitany T; Meszaros K; Lenzinger E; Schindler SD; Barnas C; Fuchs K; Sieghart W; Aschauer HN; Kasper S
    Schizophr Res; 1998 Jul; 32(2):101-6. PubMed ID: 9713905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of CYP2D6 and CYP1A2 gene polymorphism with tardive dyskinesia in Chinese schizophrenic patients.
    Fu Y; Fan CH; Deng HH; Hu SH; Lv DP; Li LH; Wang JJ; Lu XQ
    Acta Pharmacol Sin; 2006 Mar; 27(3):328-32. PubMed ID: 16490169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytochrome P-450 2D6*10 C188T polymorphism is associated with antipsychotic-induced persistent tardive dyskinesia in Chinese schizophrenic patients.
    Liou YJ; Wang YC; Bai YM; Lin CC; Yu SC; Liao DL; Lin MW; Chen JY; Lai IC
    Neuropsychobiology; 2004; 49(4):167-73. PubMed ID: 15118351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of tardive dyskinesia with variation in CYP2D6: Is there a role for active metabolites?
    Koola MM; Tsapakis EM; Wright P; Smith S; Kerwin Rip RW; Nugent KL; Aitchison KJ
    J Psychopharmacol; 2014 Jul; 28(7):665-70. PubMed ID: 24595968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymorphic variations in GSTM1, GSTT1, PgP, CYP2D6, CYP3A5, and dopamine D2 and D3 receptors and their association with tardive dyskinesia in severe mental illness.
    de Leon J; Susce MT; Pan RM; Koch WH; Wedlund PJ
    J Clin Psychopharmacol; 2005 Oct; 25(5):448-56. PubMed ID: 16160620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CYP2D6 polymorphism and tardive dyskinesia in schizophrenic patients.
    Lohmann PL; Bagli M; Krauss H; Müller DJ; Schulze TG; Fangerau H; Ludwig M; Barkow K; Held T; Heun R; Maier W; Rietschel M; Rao ML
    Pharmacopsychiatry; 2003; 36(2):73-8. PubMed ID: 12734765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic susceptibility to tardive dyskinesia in chronic schizophrenia subjects: I. Association of CYP1A2 gene polymorphism.
    Tiwari AK; Deshpande SN; Rao AR; Bhatia T; Mukit SR; Shriharsh V; Lerer B; Nimagaonkar VL; Thelma BK
    Pharmacogenomics J; 2005; 5(1):60-9. PubMed ID: 15505641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association analysis of polymorphisms in the N-methyl-D-aspartate (NMDA) receptor subunit 2B (GRIN2B) gene and tardive dyskinesia in schizophrenia.
    Liou YJ; Wang YC; Chen JY; Bai YM; Lin CC; Liao DL; Chen TT; Chen ML; Mo GH; Lai IC
    Psychiatry Res; 2007 Dec; 153(3):271-5. PubMed ID: 17669510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liver enzyme
    Lu JY; Tiwari AK; Freeman N; Zai GC; Luca V; Müller DJ; Tampakeras M; Herbert D; Emmerson H; Cheema SY; King N; Voineskos AN; Potkin SG; Lieberman JA; Meltzer HY; Remington G; Kennedy JL; Zai CC
    Pharmacogenomics; 2020 Oct; 21(15):1065-1072. PubMed ID: 32969762
    [No Abstract]   [Full Text] [Related]  

  • 11. Cytochrome P450 2D6 genotyping and association with tardive dyskinesia in Chinese schizophrenic patients.
    Lam LC; Garcia-Barcelo MM; Ungvari GS; Tang WK; Lam VK; Kwong SL; Lau BS; Kwong PP; Waye MM; Chiu HF
    Pharmacopsychiatry; 2001 Nov; 34(6):238-41. PubMed ID: 11778144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic susceptibility to Tardive Dyskinesia in chronic schizophrenia subjects: V. Association of CYP1A2 1545 C>T polymorphism.
    Tiwari AK; Deshpande SN; Lerer B; Nimgaonkar VL; Thelma BK
    Pharmacogenomics J; 2007 Oct; 7(5):305-11. PubMed ID: 16969362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tardive dyskinesia and debrisoquine 4-hydroxylase (CYP2D6) genotype in Japanese schizophrenics.
    Ohmori O; Suzuki T; Kojima H; Shinkai T; Terao T; Mita T; Abe K
    Schizophr Res; 1998 Jul; 32(2):107-13. PubMed ID: 9713906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abnormal movements and tardive dyskinesia in smokers and nonsmokers with schizophrenia genotyped for cytochrome P450 2D6.
    Ellingrod VL; Schultz SK; Arndt S
    Pharmacotherapy; 2002 Nov; 22(11):1416-9. PubMed ID: 12432967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic association of BDNF val66met and GSK-3beta-50T/C polymorphisms with tardive dyskinesia.
    Park SW; Lee JG; Kong BG; Lee SJ; Lee CH; Kim JI; Kim YH
    Psychiatry Clin Neurosci; 2009 Aug; 63(4):433-9. PubMed ID: 19457211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for association of the GLI2 gene with tardive dyskinesia in patients with chronic schizophrenia.
    Greenbaum L; Alkelai A; Rigbi A; Kohn Y; Lerer B
    Mov Disord; 2010 Dec; 25(16):2809-17. PubMed ID: 20939080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacogenetics of tardive dyskinesia in schizophrenia: The role of
    Boiko AS; Ivanova SA; Pozhidaev IV; Freidin MB; Osmanova DZ; Fedorenko OY; Semke AV; Bokhan NA; Wilffert B; Loonen AJM
    World J Biol Psychiatry; 2020 Jan; 21(1):72-77. PubMed ID: 30623717
    [No Abstract]   [Full Text] [Related]  

  • 18. The coding-synonymous polymorphism rs1045280 (Ser280Ser) in beta-arrestin 2 (ARRB2) gene is associated with tardive dyskinesia in Chinese patients with schizophrenia.
    Liou YJ; Wang YC; Chen JY; Chen ML; Chen TT; Bai YM; Lin CC; Liao DL; Lai IC
    Eur J Neurol; 2008 Dec; 15(12):1406-8. PubMed ID: 19049562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association analysis of the dopamine D3 receptor gene ser9gly and brain-derived neurotrophic factor gene val66met polymorphisms with antipsychotic-induced persistent tardive dyskinesia and clinical expression in Chinese schizophrenic patients.
    Liou YJ; Liao DL; Chen JY; Wang YC; Lin CC; Bai YM; Yu SC; Lin MW; Lai IC
    Neuromolecular Med; 2004; 5(3):243-51. PubMed ID: 15626824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Support for an association of the C939T polymorphism in the human DRD2 gene with tardive dyskinesia in schizophrenia.
    Mo GH; Lai IC; Wang YC; Chen JY; Lin CY; Chen TT; Chen ML; Liou YJ; Liao DL; Bai YM; Lin CC
    Schizophr Res; 2007 Dec; 97(1-3):302-4. PubMed ID: 17669630
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.